To define the composition of the vaginal microbiome in healthy and pregnant women, a number of large clinical studies have now been initiated by the Center for Translational Microbiome Research (CTMR) in collaboration with Uppsala University Hospital. CTMR started in January 2016 as collaboration between SciLifeLab, KI and the Swiss company Ferring Pharmaceuticals to establish a broad technical, biological, clinical and epidemiological platform for studying microbial communities in humans in the area of gastroenterology and reproductive health.
Last week, recruitment started in VaMiGyn (Vaginal microbiome and gynecological health). The study recruits 2500 women and collects microbiome samples from the mouth, gut and vagina together with clinical metadata.
